ArticleJournal of cancer research and clinical oncology2023

HAPLN3 inhibits apoptosis and promotes EMT of clear cell renal cell carcinoma via ERK and Bcl-2 signal pathways.

Yi Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.